SYRMA NSI Week ended 31 Jul 2026

Weekly Investor Report

Syrma SGS Technology Limited · Technology · Electronic Components

Open interactive chart View report data
Latest close 1,367 INR
6.1% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 35.5% above the Trend Line and sits at 87.9% of its 52-week range. The latest completed week returned 6.1%, after a -0.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 60/100.

Setup score 74 out of 100
Latest Close 1,367 INR 31 Jul 2026
1W Return 6.1% latest completed week
4W Return -0.7% short-term follow-through
12W Return 24.2% quarterly tape
Trend Breadth 71.2% 37 of 52 weeks active
Volume Ratio 2.6x vs 13-week average
What is working
  • The trend backdrop is active with a 16-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 8 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 6.1% Latest completed week; four-week move -0.7%. Indicator stack 84/69 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 60/100 30 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 35.5% above the Trend Line and sits at 87.9% of its 52-week range. The latest completed week returned 6.1%, after a -0.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9112-week average 0.89

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.91Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers88 reversal markers

No recent accumulation markers. 8 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -0.7% over four weeks, 24.2% over 12 weeks, and 83.0% over one year. The current trend has remained active for 16 consecutive weeks.

Performance by holding period

1W6.1%
4W-0.7%
12W24.2%
26W79.6%
52W83.0%
Active trend streak16 weeks
Active weeks in one year37
Trend breadth71.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.20Latest activity-pressure read.
Pressure change-35.0%Four-week change in activity pressure.
Leadership50.97Latest relative-leadership reading.
RS change-17.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength21/100Blend of value, momentum, and quality. Underlying universe rank 80; rank 1 is best.
Value6/100Relative valuation strength. Underlying universe rank 95; rank 1 is best.
Quality41/100Profitability and accounting quality. Underlying universe rank 60; rank 1 is best.
Momentum97/100Medium-term price momentum. Underlying universe rank 4; rank 1 is best.
Growth93/100Revenue and earnings growth. Underlying universe rank 8; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework17/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
78.1x
Price divided by trailing earnings.
Price / sales
5.1x
Market value relative to trailing revenue.
EV / EBITDA
43.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
0.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
25.6%
Gross profit retained from each unit of revenue.
Operating margin
9.4%
Operating profit retained from revenue.
Free-cash-flow margin
2.0%
Free cash flow generated from revenue.
Return on invested capital
11.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
27.3%
Latest one-year revenue growth.
EPS growth
72.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.1%
Cash dividends relative to market value.
Buyback yield
-3.9%
Net share repurchases relative to market value.
Shareholder yield
-3.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment60/100

Weighted news tone is neutral across 30 relevant articles.

13 positive · 17 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-6.9%Distance below the 52-week high.
13-week volatility6.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+14.7%Week of 8 May.
Worst week-7.9%Week of 15 May.
Latest week+6.1%Week of 31 Jul.

Shape of recent returns

Strong gains12
Modest gains3
Flat weeks0
Modest losses4
Sharp losses7
Recent vol6.9%13-week weekly-return volatility.
Base vol6.4%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew6.5% / -3.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape74/100

Trend, activity pressure, participation, and risk combine to a 74/100 tape read.

 Indicator analysis82/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.91; 8 reversal markers Factors38/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 88 SVQF17/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 1317.0 of 1590 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment60/100

Weighted news tone is neutral across 30 relevant articles.

Buy Syrma SGS Technology; target of Rs 1770: Motilal Oswal Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20261,367 INR6.1%1,009 INR651.7 INR1.2050.9714.8MOn
24 Jul 20261,288 INR-5.2%987.7 INR645.9 INR1.4047.953.5MOn
17 Jul 20261,359 INR-6.4%969.3 INR640.7 INR1.7354.473.2MOn
10 Jul 20261,452 INR5.5%948.4 INR634.9 INR1.9068.367.3MOn
3 Jul 20261,376 INR-4.5%924.6 INR628.7 INR1.8462.036.7MOn
26 Jun 20261,440 INR8.0%903.5 INR622.7 INR1.7774.280On
19 Jun 20261,334 INR5.3%882.8 INR616.3 INR1.6465.22899.5KOn
12 Jun 20261,267 INR3.3%866.2 INR610.5 INR1.4662.77844.0KOn
5 Jun 20261,227 INR12.7%853.8 INR605.2 INR1.3862.46737.1KOn
29 May 20261,089 INR4.8%839.6 INR599.9 INR1.4645.744.3MOn
22 May 20261,039 INR2.5%830.4 INR595.4 INR1.4540.165.9MOn
15 May 20261,013 INR-7.9%821.6 INR591.1 INR1.5139.0518.7MOn
8 May 20261,100 INR14.7%814.0 INR586.6 INR1.5449.687.5MOn
1 May 2026959.0 INR-1.1%805.5 INR581.6 INR1.1833.613.1MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.